These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4343629)

  • 61. Effect of colchicine on long lasting synaptic modifications induced by hyperactivity.
    Donoso AL; Fernandez HL
    Experientia; 1973 Sep; 29(9):1089-90. PubMed ID: 4355417
    [No Abstract]   [Full Text] [Related]  

  • 62. [Study of secondary alkaloids prepared during synthesis of papaverine].
    DETRIE J; BURKHARD J
    Prod Pharm; 1950 Dec; 5(12):520-1. PubMed ID: 14816449
    [No Abstract]   [Full Text] [Related]  

  • 63. Antagonism of dopamine-mediated inhibition in the nigro-striatal pathway: a mode of action of some catatonia-inducing drugs.
    Gonzalez-Vegas JA
    Brain Res; 1974 Nov; 80(2):219-28. PubMed ID: 4371023
    [No Abstract]   [Full Text] [Related]  

  • 64. [Some aspects of the physiological role of dopamine as a synaptic transmitter in basal ganglia and caudate nucleus].
    Kostowski W
    Acta Physiol Pol; 1972; 23():97-114. PubMed ID: 4338739
    [No Abstract]   [Full Text] [Related]  

  • 65. Nigro-striatal pathway: stimulation-evoked release of ( 3 H)dopamine from caudate nucleus.
    Voigtlander PF; Moore KE
    Brain Res; 1971 Dec; 35(2):580-3. PubMed ID: 5135554
    [No Abstract]   [Full Text] [Related]  

  • 66. Actions of papaverine and bulbocapnine on synaptic transmission in the nigro-striatal pathway in the rat.
    Gonzalez-Vegas JA
    J Physiol; 1972 Oct; 226(2):102P. PubMed ID: 4343629
    [No Abstract]   [Full Text] [Related]  

  • 67. Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus.
    Scheel-Krüger J; Magelund G; Olianas MC
    Adv Biochem Psychopharmacol; 1981; 30():165-86. PubMed ID: 7036675
    [No Abstract]   [Full Text] [Related]  

  • 68. Recent finding on dopaminergic transmission in the basal ganglia.
    Glowinski J
    Adv Neurol; 1990; 53():67-73. PubMed ID: 2173377
    [No Abstract]   [Full Text] [Related]  

  • 69. Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
    Gale K; Casu M
    Mol Cell Biochem; 1981 Sep; 39():369-405. PubMed ID: 6118827
    [No Abstract]   [Full Text] [Related]  

  • 70. Electrophysiology of the nigro-putamen dopamine pathway.
    York DH
    Pharmacol Ther B; 1976; 2(1):1-7. PubMed ID: 772715
    [No Abstract]   [Full Text] [Related]  

  • 71. Role of GABA neurons in the expression of striatal motor functions.
    Di Chiara G; Porceddu ML; Imperato A; Morelli M
    Adv Biochem Psychopharmacol; 1981; 30():129-63. PubMed ID: 7036674
    [No Abstract]   [Full Text] [Related]  

  • 72. Distinct regional differences in dopamine-mediated volume transmission.
    Rice ME
    Prog Brain Res; 2000; 125():277-90. PubMed ID: 11098664
    [No Abstract]   [Full Text] [Related]  

  • 73. Role of striato-nigral substance P in the regulation of the activity of the nigro-striatal dopaminergic neurons.
    Glowinski J; Michelot R; Chéramy A
    Adv Biochem Psychopharmacol; 1980; 22():51-62. PubMed ID: 6156583
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.